Up to $100 million of non-dilutive capital from Oxford Finance LLC Extends expected cash runway to mid-2024 SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. … Continued
Oxford’s Healthcare Real Estate Group closed over $280 million in transaction volume in the first quarter of 2022, providing credit facilities ranging from $5 million to over $110 million. Q1 … Continued
Funding will support Fusion’s growing pipeline of targeted alpha therapies for the treatment of cancer ALEXANDRIA, Va. & HAMILTON, Ont. –(BUSINESS WIRE)– Oxford Finance LLC (“Oxford”), a leading specialty finance … Continued
Company Secures up to $150 Million in Non-Dilutive Funding from Oxford Finance LLC, Providing Additional Financial Flexibility Expected Cash Runway Through 2025; Supports Continued Development and Potential Commercial Launches of VS-6766 and Defactinib BOSTON–(BUSINESS WIRE)–Mar. … Continued
ALEXANDRIA, Va. and NASHVILLE, Tenn., –(BUSINESS WIRE)–Oxford Finance LLC (“Oxford”), a leading specialty finance firm focused on healthcare services and life sciences companies worldwide, today announced the closing of a … Continued
The Woodlands, Texas, March 17, 2022 – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced it entered into a loan facility with Oxford Finance LLC that provides up to $150 million in … Continued
